PFA-100 Responsive to Effect of Energy Drinks on Platelet Function
NCT02997111 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2017-06-22
Summary
This study evaluates the responsiveness of the Platelet Function Analyzer (PFA-100) to the effect of energy drinks on platelet function. Participants' will have blood drawn prior to and 60 minutes after ingesting 250ml of a commercially available sugar-free energy drink.
Conditions
- Platelet Function
- Thrombosis
Interventions
- DEVICE
-
PFA-100
The PFA-100 will be used to assess platelet function before and after energy drink consumption.
Sponsors & Collaborators
-
St. Louis University
lead OTHER
Principal Investigators
-
Katherine Newsham, PhD · St. Louis University
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-02-14
- Primary Completion
- 2017-06-09
- Completion
- 2017-06-20
Countries
- United States
Study Locations
More Related Trials
-
A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Single and Multiple Ascending Doses of GDC-0334 and the Effect of Food on the Pharmacokinetics of GDC-0334 in Healthy Adult Participants
NCT03381144 ·Status: TERMINATED ·Phase: PHASE1
-
A Study To Understand Safety And Plasma Concentrations Of PF-06669571 During And Following The Oral Administration Of Single And Multiple Doses Of PF-06669571 In Healthy Volunteers Under Fasted And Fed Conditions
NCT02184429 ·Status: COMPLETED ·Phase: PHASE1
-
A Food Effect Study in Healthy Volunteers With Belzutifan (PT2977, MK-6482) Tablets
NCT03445169 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects
NCT00619346 ·Status: TERMINATED ·Phase: PHASE1
-
Food Effect Study to Evaluate the Effect of High-Fat Meal on the Relative Bioavailability of PF-07321332 Boosted With Ritonavir in Healthy Adult Participants
NCT05129475 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Safety and PK Study of OLT1177 Capsules
NCT02134964 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04629991 in Healthy Volunteers
NCT00797342 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy Subjects
NCT02871037 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing PF-05089771 TS Tablet to PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And Fed State
NCT01563497 ·Status: COMPLETED ·Phase: PHASE1
-
Food Effect Study for PF-06372865
NCT02217787 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-61393215 in Healthy Participants
NCT02812251 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult Participants
NCT04323124 ·Status: TERMINATED ·Phase: PHASE1
-
Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of PAT-1251 in Healthy Adult Subjects
NCT02852551 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted State
NCT01690351 ·Status: COMPLETED ·Phase: PHASE1
-
A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649
NCT02151617 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects
NCT01636141 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability With PF-05089771 Capsule Versus Oral Dispersion
NCT01854996 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke
NCT03860506 ·Status: COMPLETED ·Phase: PHASE1
-
A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Oral Doses Of PF-06273340
NCT01601834 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People
NCT05411588 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-03864086 In Healthy Male Subjects
NCT00747058 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of JNJ-54175446 in Healthy Participants
NCT02475148 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)
NCT06629402 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers. The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be Investigated
NCT01165723 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Understand How Radiolabelled PF-04449913 Is Taken Up By The Body, Broken Down And Then Removed From The Body
NCT02110342 ·Status: COMPLETED ·Phase: PHASE1